Varenicline and Combined NRT for Smoking Cessation
Status:
Active, not recruiting
Trial end date:
2022-12-31
Target enrollment:
Participant gender:
Summary
This randomized pilot phase IV trial studies the side effects and how well varenicline works
compared to nicotine replacement therapy in helping patients that smoke to quit. Varenicline
is a drug that acts the same way as nicotine in the brain but is not habit-forming. Nicotine
replacement therapy consists of nicotine patches and lozenges. It is not yet known if
varenicline is more effective than nicotine replacement therapy in helping patients quit
smoking.
Phase:
Phase 4
Details
Lead Sponsor:
M.D. Anderson Cancer Center
Collaborators:
NAL Pharmaceuticals National Cancer Institute (NCI) Pfizer